Detection of Urinary Human Chorionic Gonadotropin (hCG)

NCT05458778 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-05-01

No results posted yet for this study

Summary

The Mira Pregnancy Test is an over-the-counter urine hCG test intended for early detection of pregnancy. The test is indicated for use four days before the expected period. Throughout this study, volunteers with non-medical backgrounds were recruited to test hCG with urine samples using the Mira Pregnancy Test during the not pregnancy cycle or pregnancy cycle. To perform the study, a total number of more than 200 volunteers will be recruited to participate in the study.

Conditions

  • Pregnancy Detection

Interventions

DEVICE

Daily test with urine by the product

Women perform the hCG test and share the test results

Sponsors & Collaborators

  • Quanovate Tech Inc.

    lead INDUSTRY

Principal Investigators

  • Ning Li, MS · Quanovate Tech Inc.

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-29
Primary Completion
2023-10-31
Completion
2023-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05458778 on ClinicalTrials.gov